[8] The analysis concluded that these drugs, taken long term, could be most useful in patients who have repeated, prolonged or severe exacerbations of COPD. Hence, in some European and extra ...

The drug was introduced as a mucolytic agent for chronic pulmonary diseases more than 10 years ago. Its effect is based on the breaking of the disulfide bridges of mucus glycoproteins, resulting ...